...Large and increasing burden of disease suggests a significant unmet demand for pharmaceuticals. ...Financial sustainability of the health insurance scheme. Insecurities in the political system have grown in recent years As well as facing political challenges, the next two years will see the Bongo government contend with a weaker economic outlook
...In our Q--- Pharmaceutical Risk/Reward Index, Gabon s score of --.- out of --- marks a moderate worsening compared to its score of --.- in the previous quarter. However, it is ranked as the eighth most attractive market in Africa, and has risen by one position on our index - ranking --th place out of -- countries analysed in the Middle East and Africa region. ...In our Q--- Pharmaceutical Risk/Reward Index, Gabon s score of --.- out of --- marks a moderate worsening compared to its score of --.- in the previous quarter. However, it is ranked as the eighth most attractive market in Africa, and has risen by one position on our index - ranking --th place out of -- countries analysed in the Middle East and Africa region. The central African country still scores slightly lower than the regional average of --.-. Growth is hampered by a relatively small pharmaceutical market size in absolute terms, as well as below-average spending per capita on pharmaceuticals. However, it boasts strong sector value growth and a favourable demographic profile.
...BMI View: Gabon s small pharmaceutical market will continue to act as a deterrent to any local investments by multinational drugmakers. Opportunities will be largely focused within the generic drug market, yet over the long term, as the national health insurance scheme gains momentum, this will provide greater momentum for pharmaceutical expenditure. ...BMI View: Gabon s small pharmaceutical market will continue to act as a deterrent to any local investments by multinational drugmakers. Opportunities will be largely focused within the generic drug market, yet over the long term, as the national health insurance scheme gains momentum, this will provide greater momentum for pharmaceutical expenditure. The Gabonese government will struggle to increase funding for healthcare to the -- target set at the Abuja declaration, and the country will continue to rely on aid funding from external organisations. ...Opportunities will be largely focused within the generic drug market, yet over the long term, as the national health insurance scheme gains momentum, this will provide greater momentum for pharmaceutical expenditure. The Gabonese government will struggle to increase funding for healthcare to the -- target set at the Abuja declaration, and the country will continue to rely on aid funding from external organisations.
...